Prospective longitudinal evaluation of doxorubicin‐induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS)
暂无分享,去创建一个
S. Bielack | H. Jürgens | W. Stöhr | T. Langer | J. Treuner | J. Beck | M. Paulides | A. Kremers